NPI: 1275596397 · JACKSON, TN 38305 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,343 | $293K |
| 2019 | 15,462 | $435K |
| 2020 | 12,343 | $288K |
| 2021 | 8,138 | $163K |
| 2022 | 4,363 | $143K |
| 2023 | 4,156 | $163K |
| 2024 | 1,524 | $98K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 33,403 | 2,365 | $1.51M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,585 | 801 | $65K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,428 | 554 | $4K |
| J1756 | Injection, iron sucrose, 1 mg | 691 | 166 | $316.80 |
| A4657 | Syringe, with or without needle, each | 857 | 690 | $0.00 |
| 83550 | 425 | 392 | $0.00 | |
| 82728 | 344 | 310 | $0.00 | |
| 82306 | 138 | 128 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 71 | 39 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 34 | 31 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 50 | 24 | $0.00 |
| 90674 | 17 | 16 | $0.00 | |
| 85041 | 792 | 720 | $0.00 | |
| 85048 | 794 | 720 | $0.00 | |
| 85045 | 603 | 548 | $0.00 | |
| 83970 | 649 | 571 | $0.00 | |
| 83540 | 448 | 404 | $0.00 |